Oncogene-linked in situ immunotherapy of pre-B lymphoma arising in E mu/ret transgenic mice.

We attempted to induce anti-tumour immunity for rejecting pre-B lymphoma derived from E mu/ret transgenic mice (TGM). We established pre-B-lymphoma cell lines of C57BL/6 x Balb/c background (H-2b/d) into which H-2k alloantigen and C3H background were introduced (retL1-6 and retL6-6), and we inoculat...

Descripción completa

Detalles Bibliográficos
Autores principales: Ichihara, M., Iwamoto, T., Isobe, K., Takahashi, M., Nakayama, A., Pu, M., Dai, Y., Parashar, A., Ohkus, K., Kato, M.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1995
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033753/
https://www.ncbi.nlm.nih.gov/pubmed/7710948

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033753/
https://www.ncbi.nlm.nih.gov/pubmed/7710948

Ejemplares similares